Identification |
Name: | Ketanserin |
Synonyms: | Ketanserine [INN-French];3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione;Ketanserinum [INN-Latin];R 41468;Ketanserin (USAN);Ketanserina [INN-Spanish];2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-;R 41,468;Ketanserin [USAN:BAN:INN];3-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2,4-(1H,3H)-quinazolinedione; |
CAS: | 74050-98-9 |
EINECS: | 277-680-2 |
Molecular Formula: | C22H22FN3O3 |
Molecular Weight: | 395.43 |
Molecular Structure: |
|
Properties |
Density: | 1.281 g/cm3 |
Stability: | Stable if stored as directed. |
Refractive index: | 1.592 |
Water Solubility: | DMF: 10 mg/mL, clear, colorless |
Solubility: | DMF: 10 mg/mL, clear, colorless |
Appearance: | White to off-white solid. |
Specification: | Off-White Solid usageEng:An antihypertensive, with affinity for multiple GPCR receptors. |
Storage Temperature: | 2-8°C |
Usage: | Classified as an antihypertensive, serotonin antagonist. |
Safety Data |
|
|